“In silico docking studies of RP2 (X-Linked retinitis pigmentosa) protein using anthocyanins as potential inhibitors”, Bangladesh J Pharmacol, vol. 8, no. 3, pp. 292–299, Jun. 2013, doi: 10.3329/bjp.v8i3.15110.